#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Primary amyloidosis Hydrocephalus Primary biliary cholangitis Stevens-Johnson syndrome Thromboangiitis obliterans Peripheral T-cell lymphoma unspecified Paraneoplastic neurological syndrome Meningitis meningococcal Stress cardiomyopathy Mantle cell lymphoma refractory Primary adrenal insufficiency Myasthenia gravis Guillain-Barre syndrome Pituitary-dependent Cushing's syndrome Friedreich's ataxia More trials…

    Learn about Rare Diseases

    Paraneoplastic neurological syndrome – Trials in Disease Castleman’s disease – Life with Disease Leiomyosarcoma – Trials in Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Behcet’s syndrome – Basic Information Glycogen storage disease type II – Life with Disease Chondrosarcoma – Basic Information Basal cell naevus syndrome – Diagnostics Stevens-Johnson syndrome Pemphigus – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Specific Nucleic Acid Sna-Her1 Vilanterol Mezigdomide Linrodostat Mesilate MB-001 Db-1303 Acoramidis Hydrochloride Lovastatin Midazolam Hydrochloride Bortezomib Ro7269162 ACARBOSE ZIMISLECEL Xevinapant Riociguat ENSIFENTRINE Cetirizine Relebactam Vh4524184 Cyclophosphamide Monohydrate More therapies…

    Learn about Your Condition

    Metastatic gastric cancer Erythema migrans Stomatitis Genitourinary tract neoplasm Neuroendocrine carcinoma Hyperparathyroidism secondary Haemorrhage Retroperitoneal cancer Bile acid synthesis disorder Psychotic behaviour Fatty acid oxidation disorder Contusion Eyelid ptosis Hypomagnesaemia Plasma cell leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. IRCCS Humanitas Research Hospital

IRCCS Humanitas Research Hospital

Via Alessandro Manzoni 56, Rozzano, 20089, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Tezepelumab for Symptom Relief in Patients Aged 12-80 with Eosinophilic Esophagitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tezepelumab
    Austria Belgium Czechia Denmark Finland Germany +7

  • Study on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis

    Not recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    Investigated Drugs:
    • Fipaxalparant
    Austria France Germany Greece Italy Poland +3

  • Study on Nanatinostat and Valganciclovir for Patients with Epstein-Barr Virus-Positive Relapsed or Refractory Lymphomas

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Epstein-Barr virus associated lymphoma
    Investigated Drugs:
    • Ganciclovir Sodium
    • Nanatinostat
    • Valganciclovir
    France Germany Italy Spain

  • Study on the Effects of Riliprubart for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic inflammatory demyelinating polyradiculoneuropathy
    Investigated Drugs:
    • Riliprubart
    France Germany Italy The Netherlands Poland Spain

  • Study of Cemiplimab Compared to Placebo After Surgery and Radiation for Patients with High-Risk Skin Squamous Cell Carcinoma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of skin
    Investigated Drugs:
    • Cemiplimab
    Belgium France Germany Greece Ireland Italy +2

  • Study on Rezafungin to Prevent Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Rezafungin Acetate
    • Fluconazole
    • Posaconazole
    Belgium France Germany Italy Spain

  • Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Arteriosclerosis
    Investigated Drugs:
    • Atorvastatin
    • Inclisiran
    • Rosuvastatin
    Austria Belgium Bulgaria Croatia Czechia Denmark +18

  • Study on the Effectiveness and Safety of Olorofim vs. Liposomal Amphotericin B for Patients with Invasive Aspergillosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Fungal infection
    Investigated Drugs:
    • Olorofim
    • Amphotericine B, Liposome
    Belgium France Germany Italy The Netherlands Spain

  • Study on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Amlitelimab
    • Pimecrolimus
    • Tacrolimus
    Bulgaria Czechia Denmark France Germany Greece +5

  • Study Comparing Risankizumab and Deucravacitinib for Adults with Moderate Plaque Psoriasis Eligible for Systemic Therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Deucravacitinib
    • Risankizumab
    Belgium Germany Greece Hungary Italy The Netherlands +1
Previous Page
1 … 55 56 57 58 59 … 69
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!